These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16012278)

  • 1. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence.
    Anton RF; Moak DH; Latham P; Waid LR; Myrick H; Voronin K; Thevos A; Wang W; Woolson R
    J Clin Psychopharmacol; 2005 Aug; 25(4):349-57. PubMed ID: 16012278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
    Anton RF; Moak DH; Waid LR; Latham PK; Malcolm RJ; Dias JK
    Am J Psychiatry; 1999 Nov; 156(11):1758-64. PubMed ID: 10553740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.
    Balldin J; Berglund M; Borg S; Månsson M; Bendtsen P; Franck J; Gustafsson L; Halldin J; Nilsson LH; Stolt G; Willander A
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1142-9. PubMed ID: 12878920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of dropout in an outpatient treatment for problem drinkers including cognitive-behavioral therapy and the opioid antagonist naltrexone.
    Vuoristo-Myllys S; Lahti J; Alho H; Julkunen J
    J Stud Alcohol Drugs; 2013 Nov; 74(6):894-901. PubMed ID: 24172116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.
    O'Malley SS; Rounsaville BJ; Farren C; Namkoong K; Wu R; Robinson J; O'Connor PG
    Arch Intern Med; 2003 Jul; 163(14):1695-704. PubMed ID: 12885685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome predictors for problem drinkers treated with combined cognitive behavioral therapy and naltrexone.
    Vuoristo-Myllys S; Lipsanen J; Lahti J; Kalska H; Alho H
    Am J Drug Alcohol Abuse; 2014 Mar; 40(2):103-10. PubMed ID: 24456403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial.
    Heinälä P; Alho H; Kiianmaa K; Lönnqvist J; Kuoppasalmi K; Sinclair JD
    J Clin Psychopharmacol; 2001 Jun; 21(3):287-92. PubMed ID: 11386491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism.
    Anton RF; Moak DH; Latham PK; Waid LR; Malcolm RJ; Dias JK; Roberts JS
    J Clin Psychopharmacol; 2001 Feb; 21(1):72-7. PubMed ID: 11199951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention.
    Oslin DW; Lynch KG; Pettinati HM; Kampman KM; Gariti P; Gelfand L; Ten Have T; Wortman S; Dundon W; Dackis C; Volpicelli JR; O'Brien CP
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1299-308. PubMed ID: 18540910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
    Anton RF; O'Malley SS; Ciraulo DA; Cisler RA; Couper D; Donovan DM; Gastfriend DR; Hosking JD; Johnson BA; LoCastro JS; Longabaugh R; Mason BJ; Mattson ME; Miller WR; Pettinati HM; Randall CL; Swift R; Weiss RD; Williams LD; Zweben A;
    JAMA; 2006 May; 295(17):2003-17. PubMed ID: 16670409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
    O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
    Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient cognitive behavioural therapy programme for alcohol dependence: impact of naltrexone use on outcome.
    Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
    Aust N Z J Psychiatry; 2001 Aug; 35(4):443-8. PubMed ID: 11531723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
    Foa EB; Yusko DA; McLean CP; Suvak MK; Bux DA; Oslin D; O'Brien CP; Imms P; Riggs DS; Volpicelli J
    JAMA; 2013 Aug; 310(5):488-95. PubMed ID: 23925619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching.
    Jaffe AJ; Rounsaville B; Chang G; Schottenfeld RS; Meyer RE; O'Malley SS
    J Consult Clin Psychol; 1996 Oct; 64(5):1044-53. PubMed ID: 8916634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist?
    Baros AM; Latham PK; Anton RF
    Alcohol Clin Exp Res; 2008 May; 32(5):771-6. PubMed ID: 18336635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do manualized psychosocial interventions help reduce relapse among alcohol-dependent adults treated with naltrexone or placebo? A meta-analysis.
    Agosti V; Nunes EV; O'Shea D
    Am J Addict; 2012; 21(6):501-7. PubMed ID: 23082827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia.
    Petrakis IL; O'Malley S; Rounsaville B; Poling J; McHugh-Strong C; Krystal JH;
    Psychopharmacology (Berl); 2004 Mar; 172(3):291-7. PubMed ID: 14634716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended naltrexone and broad spectrum treatment or motivational enhancement therapy.
    Longabaugh R; Wirtz PW; Gulliver SB; Davidson D
    Psychopharmacology (Berl); 2009 Oct; 206(3):367-76. PubMed ID: 19639303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health status.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Aust N Z J Psychiatry; 2004 Oct; 38(10):842-8. PubMed ID: 15369544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.